rs777685454
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM5PP2PP3_StrongPP5
The NM_000083.3(CLCN1):c.1606G>A(p.Val536Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V536A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000083.3 missense
Scores
Clinical Significance
Conservation
Publications
- myotonia congenita, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myotonia congenita, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Thomsen and Becker diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLCN1 | ENST00000343257.7 | c.1606G>A | p.Val536Ile | missense_variant | Exon 15 of 23 | 1 | NM_000083.3 | ENSP00000339867.2 | ||
| CLCN1 | ENST00000432192.6 | n.*891G>A | non_coding_transcript_exon_variant | Exon 15 of 23 | 1 | ENSP00000395949.2 | ||||
| CLCN1 | ENST00000432192.6 | n.*891G>A | 3_prime_UTR_variant | Exon 15 of 23 | 1 | ENSP00000395949.2 | ||||
| CLCN1 | ENST00000650516.2 | c.1606G>A | p.Val536Ile | missense_variant | Exon 15 of 23 | ENSP00000498052.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251390 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461546Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727084 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myotonia, autosomal recessive form;C2936781:Congenital myotonia, autosomal dominant form Pathogenic:2
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 536 of the CLCN1 protein (p.Val536Ile). This variant is present in population databases (rs777685454, gnomAD 0.02%). This missense change has been observed in individual(s) with autosomal recessive myotonia congenita and late onset myotonia (PMID: 23152584, 29405036; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 447054). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function with a positive predictive value of 95%. This variant disrupts the p.Val536 amino acid residue in CLCN1. Other variant(s) that disrupt this residue have been observed in individuals with CLCN1-related conditions (PMID: 24304580), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1Uncertain:1
- -
Reported in a heterozygous state in an individual with a personal and family history of myotonia congenita (PMID: 28325641); Reported in patients with myotonia who also harbored as second CLCN1 variant, phase unknown (PMID: 23152584, 34529042); In silico analysis indicates that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23152584, 31589614, 29405036, 34529042, 24304580, 28325641) -
Congenital myotonia, autosomal recessive form Pathogenic:1
The CLCN1 c.1606G>A (p.Val536Ile) variant has been observed in individuals with autosomal recessive myotonia congenita and late onset myotonia (Raheem O et al, Ferese R et al). This p.Val536Ile variant has allele frequency of 0.002829% in the gnomAD and novel (not in any individuals) in 1000 genome database. It has been submitted to ClinVar with varying interpretations: Pathogenic/ Likely Pathogenic. The amino acid Val at position 536 is changed to a Ile changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Val536Ile in CLCN1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at